Tags:AnalyticsArtificial IntelligenceBioTechDataDevelopmentDrugHealthTechLearnPersonalTechnology
Healx is a mission-driven technology company pioneering the next generation of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. There are 7,000 known rare diseases that affect 400 million people across the globe, but only 5% of those conditions have an approved treatment. By combining frontier AI technology with deep drug discovery and development expertise, Healx can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to meet this huge unmet need and have unprecedented patient impact.
Location: United Kingdom, England, Cambridge
Member count: 51-200
Total raised: $68.056282M
Founded date: 2014

Investors 6

Funding Rounds 3

DateSeriesAmountInvestorsDeal News
07.11.2019Series B$56.146428...-cambridgen...
26.07.2018Series A$10M-tech.eu/br...
04.10.2016Series A$1.909854MAmadeus Ca...cambridgen...

Mentions in press and media 57

DateTitleDescriptionCategoryAuthorSource
09.02.2022Healx and ...Healx and Ovid Therapeutics en...--cambridgen...
21.11.2021Europe’s A...Did you miss a session from th...-Tim Guilli...venturebea...
21.11.2021Europe’s A...We are excited to bring Transf...-Tim Guilli...venturebea...
22.10.2021Healx rece...Healx receives IND and Orphan ...--cambridgen...
22.10.2021Healx rece...Healx has received Investigati...--cambridgen...
20.10.2021UK startup...There are currently no approve...AI, biotec...Emma Betue...techcrunch...
12.08.2021Healx laun...Healx, the AI-powered, patient...--cambridgen...
12.08.2021Healx laun...Healx launches AI-powered indi...--cambridgen...
30.06.2021Tech.eu Po...The Tech.eu Podcast is a show ...--tech.eu/ne...
23.06.2021Internatio...International Women in Enginee...--digit.fyi/...
Show more